论文信息 - Beta Adrenergic Signaling Promotes Drug Resistance in Sarcomas - 字舞流文

Beta Adrenergic Signaling Promotes Drug Resistance in Sarcomas

This research was supported by CFANS Research Apprenticeship Program, Sarcoma Foundation of America, Morris Animal Foundation, and the Undergraduate Research Opportunities Program (UROP).

E. Dickerson | K. Fox

[1] A. Sanda. 2000 AND BEYOND , 2018, Regional Policy.

[2] J. Blay,et al. Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region , 2010, BMC Cancer.

[3] Y. Robin,et al. Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases , 2008, Sarcoma.

[4] C. Antonescu,et al. A 14‐Year Retrospective Review of Angiosarcoma: Clinical Characteristics, Prognostic Factors, and Treatment Outcomes with Surgery and Chemotherapy , 2005, Cancer journal.

[5] F. Collin,et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas , 2001, Cancer.

[6] C. Henry,et al. Treatment of canine hemangiosarcoma: 2000 and beyond. , 2000, Journal of veterinary internal medicine.